INTERNATIONAL PATENT: NOVARTIS AG, ADIWIJAYA, BAMBANG, CALZASCIA, THOMAS, GERGELY, PETER, PEARSON, DAVID SCOTT FILES APPLICATION FOR "RAPCABTAGENE AUTOLEUCEL FOR USE IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS"

GENEVA, Sept. 21 -- NOVARTIS AG (Lichtstrasse 354056 Basel), ADIWIJAYA, Bambang (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), CALZASCIA, Thomas (Novartis Pharma AGLichtstrasse 354056 Basel), GERGELY, Peter (Novartis Pharma AGLichtstrasse 354056 Basel), PEARSON, David Scott (Novartis Pharma AGLichtstrasse 354056 Basel) filed a patent application (PCT/IB2024/052396) for "RAPCABTAGENE AUTOLEUCEL FOR USE IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS" on Mar 12, 2024. With publication no. WO/2025/191300, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World I...